Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma Multiforme

BACKGROUND: Gliomas are the most common intracranial tumors and are classified as I–IV. Among them, glioblastoma multiforme (GBM) is the most common invasive glioma with a poor prognosis. New molecular biomarkers that can predict clinical outcomes in GBM patients must be identified, which will help...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Ji’an, Wang, Long, Xu, Zhou, Wu, Liquan, Liu, Baohui, Wang, Junmin, Tian, Daofeng, Xiong, Xiaoxing, Chen, Qianxue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136556/
https://www.ncbi.nlm.nih.gov/pubmed/32296458
http://dx.doi.org/10.3389/fgene.2020.00253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136556/
https://www.ncbi.nlm.nih.gov/pubmed/32296458
http://dx.doi.org/10.3389/fgene.2020.00253

Ejemplares similares